Loading…

Complete decongestive therapy phase 1: an expert consensus document

This document was drafted by interdisciplinary experts informed by the evidence and guided by their extensive lymphedema clinical experience at the 2023 American Cancer Society (ACS) Lymphedema Summit: Forward Momentum: Future Steps in Lymphedema Management hosted by the ACS, Lymphology Association...

Full description

Saved in:
Bibliographic Details
Published in:Medical oncology (Northwood, London, England) London, England), 2024-11, Vol.41 (12), p.304, Article 304
Main Authors: DiCecco, Shelley, Davies, Claire C., Gilchrist, Laura, Levenhagen, Kim, Letellier, Marie-Eve, Rivera, Amy, Weiss, Jan, Klose, Guenter, Hodgkins, Linda, Anderson, Elizabeth, Cheville, Andrea, Moore, Keith, Koehler, Linda
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c300t-6e5543a147b75a45299ab559f97faf37071c865d934d29696078e539b832b3e63
container_end_page
container_issue 12
container_start_page 304
container_title Medical oncology (Northwood, London, England)
container_volume 41
creator DiCecco, Shelley
Davies, Claire C.
Gilchrist, Laura
Levenhagen, Kim
Letellier, Marie-Eve
Rivera, Amy
Weiss, Jan
Klose, Guenter
Hodgkins, Linda
Anderson, Elizabeth
Cheville, Andrea
Moore, Keith
Koehler, Linda
description This document was drafted by interdisciplinary experts informed by the evidence and guided by their extensive lymphedema clinical experience at the 2023 American Cancer Society (ACS) Lymphedema Summit: Forward Momentum: Future Steps in Lymphedema Management hosted by the ACS, Lymphology Association of North America, and the Washington School of Medicine  in St. Louis, Missouri. Consensus statements were derived from a facilitated workshop and multiple follow-up discussions and meetings combining available evidence and clinical expertise. The consensus statements find that the essential components of complete decongestive therapy (CDT) are examination, compression, manual techniques (this may include but is not limited to manual lymph drainage), exercise, skin care, education, and self-management. Adjunctive interventions and alternatives may complement CDT. CDT should be provided by specifically trained healthcare practitioners in lymphedema management, preferably a certified lymphedema therapist. The individual’s lymphedema etiology and presentation, comorbidities, and other pertinent clinical information will determine the components of CDT applied and the frequency and duration of care.
doi_str_mv 10.1007/s12032-024-02407-4
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3123549382</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3123190606</sourcerecordid><originalsourceid>FETCH-LOGICAL-c300t-6e5543a147b75a45299ab559f97faf37071c865d934d29696078e539b832b3e63</originalsourceid><addsrcrecordid>eNp9kMtKxDAUhoMozjj6Ai4k4MZNNdemcSfFGwhuFNyFtD11ZujNpBXn7c1MxwsuXIQE8p3__HwIHVNyTglRF54ywllEmFgfoiKxg6ZUSh1RTl92f70n6MD7JSGMSqb30YRrkSgm5BSlaVt3FfSAC8jb5hV8v3gH3M_B2W6Fu7n1gOkltg2Gjw5cjwPlofGDx0WbDzU0_SHaK23l4Wh7z9DzzfVTehc9PN7ep1cPUc4J6aMYpBTcUqEyJa0ITbTNQsNSq9KWXBFF8ySWheaiYDrWMVEJSK6zhLOMQ8xn6GzM7Vz7NoSmpl74HKrKNtAO3nDKuBSaJyygp3_QZTu4JrTbUFSTmKwD2UjlrvXeQWk6t6itWxlKzFqxGRWboNdsFBsRhk620UNWQ_E98uU0AHwEfPgKRt3P7n9iPwEg3oRr</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3123190606</pqid></control><display><type>article</type><title>Complete decongestive therapy phase 1: an expert consensus document</title><source>Springer Link</source><creator>DiCecco, Shelley ; Davies, Claire C. ; Gilchrist, Laura ; Levenhagen, Kim ; Letellier, Marie-Eve ; Rivera, Amy ; Weiss, Jan ; Klose, Guenter ; Hodgkins, Linda ; Anderson, Elizabeth ; Cheville, Andrea ; Moore, Keith ; Koehler, Linda</creator><creatorcontrib>DiCecco, Shelley ; Davies, Claire C. ; Gilchrist, Laura ; Levenhagen, Kim ; Letellier, Marie-Eve ; Rivera, Amy ; Weiss, Jan ; Klose, Guenter ; Hodgkins, Linda ; Anderson, Elizabeth ; Cheville, Andrea ; Moore, Keith ; Koehler, Linda</creatorcontrib><description>This document was drafted by interdisciplinary experts informed by the evidence and guided by their extensive lymphedema clinical experience at the 2023 American Cancer Society (ACS) Lymphedema Summit: Forward Momentum: Future Steps in Lymphedema Management hosted by the ACS, Lymphology Association of North America, and the Washington School of Medicine  in St. Louis, Missouri. Consensus statements were derived from a facilitated workshop and multiple follow-up discussions and meetings combining available evidence and clinical expertise. The consensus statements find that the essential components of complete decongestive therapy (CDT) are examination, compression, manual techniques (this may include but is not limited to manual lymph drainage), exercise, skin care, education, and self-management. Adjunctive interventions and alternatives may complement CDT. CDT should be provided by specifically trained healthcare practitioners in lymphedema management, preferably a certified lymphedema therapist. The individual’s lymphedema etiology and presentation, comorbidities, and other pertinent clinical information will determine the components of CDT applied and the frequency and duration of care.</description><identifier>ISSN: 1559-131X</identifier><identifier>ISSN: 1357-0560</identifier><identifier>EISSN: 1559-131X</identifier><identifier>DOI: 10.1007/s12032-024-02407-4</identifier><identifier>PMID: 39487245</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Consensus ; Editorial ; Exercise Therapy - standards ; Hematology ; Humans ; Internal Medicine ; Lymphedema ; Lymphedema - diagnosis ; Lymphedema - therapy ; Manual Lymphatic Drainage - methods ; Manual Lymphatic Drainage - standards ; Medicine ; Medicine &amp; Public Health ; Oncology ; Pathology ; Practice Guidelines as Topic</subject><ispartof>Medical oncology (Northwood, London, England), 2024-11, Vol.41 (12), p.304, Article 304</ispartof><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024</rights><rights>2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</rights><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c300t-6e5543a147b75a45299ab559f97faf37071c865d934d29696078e539b832b3e63</cites><orcidid>0000-0002-6375-7719 ; 0000-0002-9887-4376 ; 0000-0002-8306-1313 ; 0000-0003-4201-8113 ; 0000-0002-5460-872X ; 0000-0001-5970-6719 ; 0009-0005-0108-567X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39487245$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>DiCecco, Shelley</creatorcontrib><creatorcontrib>Davies, Claire C.</creatorcontrib><creatorcontrib>Gilchrist, Laura</creatorcontrib><creatorcontrib>Levenhagen, Kim</creatorcontrib><creatorcontrib>Letellier, Marie-Eve</creatorcontrib><creatorcontrib>Rivera, Amy</creatorcontrib><creatorcontrib>Weiss, Jan</creatorcontrib><creatorcontrib>Klose, Guenter</creatorcontrib><creatorcontrib>Hodgkins, Linda</creatorcontrib><creatorcontrib>Anderson, Elizabeth</creatorcontrib><creatorcontrib>Cheville, Andrea</creatorcontrib><creatorcontrib>Moore, Keith</creatorcontrib><creatorcontrib>Koehler, Linda</creatorcontrib><title>Complete decongestive therapy phase 1: an expert consensus document</title><title>Medical oncology (Northwood, London, England)</title><addtitle>Med Oncol</addtitle><addtitle>Med Oncol</addtitle><description>This document was drafted by interdisciplinary experts informed by the evidence and guided by their extensive lymphedema clinical experience at the 2023 American Cancer Society (ACS) Lymphedema Summit: Forward Momentum: Future Steps in Lymphedema Management hosted by the ACS, Lymphology Association of North America, and the Washington School of Medicine  in St. Louis, Missouri. Consensus statements were derived from a facilitated workshop and multiple follow-up discussions and meetings combining available evidence and clinical expertise. The consensus statements find that the essential components of complete decongestive therapy (CDT) are examination, compression, manual techniques (this may include but is not limited to manual lymph drainage), exercise, skin care, education, and self-management. Adjunctive interventions and alternatives may complement CDT. CDT should be provided by specifically trained healthcare practitioners in lymphedema management, preferably a certified lymphedema therapist. The individual’s lymphedema etiology and presentation, comorbidities, and other pertinent clinical information will determine the components of CDT applied and the frequency and duration of care.</description><subject>Consensus</subject><subject>Editorial</subject><subject>Exercise Therapy - standards</subject><subject>Hematology</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Lymphedema</subject><subject>Lymphedema - diagnosis</subject><subject>Lymphedema - therapy</subject><subject>Manual Lymphatic Drainage - methods</subject><subject>Manual Lymphatic Drainage - standards</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Oncology</subject><subject>Pathology</subject><subject>Practice Guidelines as Topic</subject><issn>1559-131X</issn><issn>1357-0560</issn><issn>1559-131X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kMtKxDAUhoMozjj6Ai4k4MZNNdemcSfFGwhuFNyFtD11ZujNpBXn7c1MxwsuXIQE8p3__HwIHVNyTglRF54ywllEmFgfoiKxg6ZUSh1RTl92f70n6MD7JSGMSqb30YRrkSgm5BSlaVt3FfSAC8jb5hV8v3gH3M_B2W6Fu7n1gOkltg2Gjw5cjwPlofGDx0WbDzU0_SHaK23l4Wh7z9DzzfVTehc9PN7ep1cPUc4J6aMYpBTcUqEyJa0ITbTNQsNSq9KWXBFF8ySWheaiYDrWMVEJSK6zhLOMQ8xn6GzM7Vz7NoSmpl74HKrKNtAO3nDKuBSaJyygp3_QZTu4JrTbUFSTmKwD2UjlrvXeQWk6t6itWxlKzFqxGRWboNdsFBsRhk620UNWQ_E98uU0AHwEfPgKRt3P7n9iPwEg3oRr</recordid><startdate>20241102</startdate><enddate>20241102</enddate><creator>DiCecco, Shelley</creator><creator>Davies, Claire C.</creator><creator>Gilchrist, Laura</creator><creator>Levenhagen, Kim</creator><creator>Letellier, Marie-Eve</creator><creator>Rivera, Amy</creator><creator>Weiss, Jan</creator><creator>Klose, Guenter</creator><creator>Hodgkins, Linda</creator><creator>Anderson, Elizabeth</creator><creator>Cheville, Andrea</creator><creator>Moore, Keith</creator><creator>Koehler, Linda</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-6375-7719</orcidid><orcidid>https://orcid.org/0000-0002-9887-4376</orcidid><orcidid>https://orcid.org/0000-0002-8306-1313</orcidid><orcidid>https://orcid.org/0000-0003-4201-8113</orcidid><orcidid>https://orcid.org/0000-0002-5460-872X</orcidid><orcidid>https://orcid.org/0000-0001-5970-6719</orcidid><orcidid>https://orcid.org/0009-0005-0108-567X</orcidid></search><sort><creationdate>20241102</creationdate><title>Complete decongestive therapy phase 1: an expert consensus document</title><author>DiCecco, Shelley ; Davies, Claire C. ; Gilchrist, Laura ; Levenhagen, Kim ; Letellier, Marie-Eve ; Rivera, Amy ; Weiss, Jan ; Klose, Guenter ; Hodgkins, Linda ; Anderson, Elizabeth ; Cheville, Andrea ; Moore, Keith ; Koehler, Linda</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c300t-6e5543a147b75a45299ab559f97faf37071c865d934d29696078e539b832b3e63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Consensus</topic><topic>Editorial</topic><topic>Exercise Therapy - standards</topic><topic>Hematology</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Lymphedema</topic><topic>Lymphedema - diagnosis</topic><topic>Lymphedema - therapy</topic><topic>Manual Lymphatic Drainage - methods</topic><topic>Manual Lymphatic Drainage - standards</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Oncology</topic><topic>Pathology</topic><topic>Practice Guidelines as Topic</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>DiCecco, Shelley</creatorcontrib><creatorcontrib>Davies, Claire C.</creatorcontrib><creatorcontrib>Gilchrist, Laura</creatorcontrib><creatorcontrib>Levenhagen, Kim</creatorcontrib><creatorcontrib>Letellier, Marie-Eve</creatorcontrib><creatorcontrib>Rivera, Amy</creatorcontrib><creatorcontrib>Weiss, Jan</creatorcontrib><creatorcontrib>Klose, Guenter</creatorcontrib><creatorcontrib>Hodgkins, Linda</creatorcontrib><creatorcontrib>Anderson, Elizabeth</creatorcontrib><creatorcontrib>Cheville, Andrea</creatorcontrib><creatorcontrib>Moore, Keith</creatorcontrib><creatorcontrib>Koehler, Linda</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Medical oncology (Northwood, London, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>DiCecco, Shelley</au><au>Davies, Claire C.</au><au>Gilchrist, Laura</au><au>Levenhagen, Kim</au><au>Letellier, Marie-Eve</au><au>Rivera, Amy</au><au>Weiss, Jan</au><au>Klose, Guenter</au><au>Hodgkins, Linda</au><au>Anderson, Elizabeth</au><au>Cheville, Andrea</au><au>Moore, Keith</au><au>Koehler, Linda</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Complete decongestive therapy phase 1: an expert consensus document</atitle><jtitle>Medical oncology (Northwood, London, England)</jtitle><stitle>Med Oncol</stitle><addtitle>Med Oncol</addtitle><date>2024-11-02</date><risdate>2024</risdate><volume>41</volume><issue>12</issue><spage>304</spage><pages>304-</pages><artnum>304</artnum><issn>1559-131X</issn><issn>1357-0560</issn><eissn>1559-131X</eissn><abstract>This document was drafted by interdisciplinary experts informed by the evidence and guided by their extensive lymphedema clinical experience at the 2023 American Cancer Society (ACS) Lymphedema Summit: Forward Momentum: Future Steps in Lymphedema Management hosted by the ACS, Lymphology Association of North America, and the Washington School of Medicine  in St. Louis, Missouri. Consensus statements were derived from a facilitated workshop and multiple follow-up discussions and meetings combining available evidence and clinical expertise. The consensus statements find that the essential components of complete decongestive therapy (CDT) are examination, compression, manual techniques (this may include but is not limited to manual lymph drainage), exercise, skin care, education, and self-management. Adjunctive interventions and alternatives may complement CDT. CDT should be provided by specifically trained healthcare practitioners in lymphedema management, preferably a certified lymphedema therapist. The individual’s lymphedema etiology and presentation, comorbidities, and other pertinent clinical information will determine the components of CDT applied and the frequency and duration of care.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>39487245</pmid><doi>10.1007/s12032-024-02407-4</doi><orcidid>https://orcid.org/0000-0002-6375-7719</orcidid><orcidid>https://orcid.org/0000-0002-9887-4376</orcidid><orcidid>https://orcid.org/0000-0002-8306-1313</orcidid><orcidid>https://orcid.org/0000-0003-4201-8113</orcidid><orcidid>https://orcid.org/0000-0002-5460-872X</orcidid><orcidid>https://orcid.org/0000-0001-5970-6719</orcidid><orcidid>https://orcid.org/0009-0005-0108-567X</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1559-131X
ispartof Medical oncology (Northwood, London, England), 2024-11, Vol.41 (12), p.304, Article 304
issn 1559-131X
1357-0560
1559-131X
language eng
recordid cdi_proquest_miscellaneous_3123549382
source Springer Link
subjects Consensus
Editorial
Exercise Therapy - standards
Hematology
Humans
Internal Medicine
Lymphedema
Lymphedema - diagnosis
Lymphedema - therapy
Manual Lymphatic Drainage - methods
Manual Lymphatic Drainage - standards
Medicine
Medicine & Public Health
Oncology
Pathology
Practice Guidelines as Topic
title Complete decongestive therapy phase 1: an expert consensus document
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T22%3A40%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Complete%20decongestive%20therapy%20phase%201:%20an%20expert%20consensus%20document&rft.jtitle=Medical%20oncology%20(Northwood,%20London,%20England)&rft.au=DiCecco,%20Shelley&rft.date=2024-11-02&rft.volume=41&rft.issue=12&rft.spage=304&rft.pages=304-&rft.artnum=304&rft.issn=1559-131X&rft.eissn=1559-131X&rft_id=info:doi/10.1007/s12032-024-02407-4&rft_dat=%3Cproquest_cross%3E3123190606%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c300t-6e5543a147b75a45299ab559f97faf37071c865d934d29696078e539b832b3e63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3123190606&rft_id=info:pmid/39487245&rfr_iscdi=true